S 1614 New Jersey Senate · 2022-2023 Regular Session

Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.

Bill status signed all 5 stages cleared

Introduction

Feb 2022

Committee Review

Jun 2023

Senate Passage

Jun 2023

General Assembly Passage

Jun 2023

Signed into Law

Jul 2023

Introduced Feb 14, 2022 Signed Jul 10, 2023

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jul 10, 2023

Signed into law

Approved P.L.2023, c.105.

executive

Jun 30, 2023

Upper · Passed

Passed Senate (Passed Both Houses) (35-0)

upper

Jun 30, 2023

Lower · Passed

Passed Assembly (77-1-0)

lower

Jun 27, 2023

Lower · Passed

Reported out of Assembly Committee with Amendments, 2nd Reading

lower

Jun 27, 2023

Committee

Recommitted to Assembly Budget Committee

lower

Jun 22, 2023

Lower · Passed

Reported out of Assembly Committee, 2nd Reading

lower

Jun 29, 2022

Committee

Received in the Assembly, Referred to Assembly Appropriations Committee

lower

Jun 29, 2022

Upper · Passed

Passed Senate (40-0)

upper

Jun 27, 2022

Upper · Passed

Reported out of Senate Committee with Amendments, 2nd Reading

upper

Mar 14, 2022

Committee

Referred to Senate Budget and Appropriations Committee

upper

Mar 14, 2022

Upper · Passed

Reported out of Senate Committee, 2nd Reading

upper

Feb 14, 2022

Introduced

Introduced in the Senate, Referred to Senate Commerce Committee

upper

8 primary · 20 co-sponsors

Sponsors

Role

Legislator

Party

State

District